Back to the main directory
Press Release
- Akari Therapeutics Announces Pre-Clinical Development Progress Toward Potential IND on Long-Acting PAS-Nomacopan for Geographic Atrophy (GA) by GlobeNewsWire
- ADDvantage Technologies Group to Report Fiscal 2022 Fourth Quarter and Year End Financial Results on March 21, 2023 by GlobeNewsWire
- UNITY Biotechnology to Participate in the SVB Securities Global Biopharma Conference by GlobeNewsWire
- MIMEDX to Host Fourth Quarter and Full Year 2022 Operating and Financial Results Conference Call on February 28 by GlobeNewsWire
- Aprea Therapeutics Announces Phase II SBIR Award from the National Cancer Institute (NCI) by GlobeNewsWire
- Jourdan Intersects 1.23% Li₂O over 4.15 m at Vallée by GlobeNewsWire
- ProPhase Labs Announces Plans for Major Expansion of its Pharmaloz Manufacturing, Inc. Subsidiary to Meet Growing Demand by GlobeNewsWire
- Otonomo Announces Fourth Quarter and Full Year 2022 Financial Results by GlobeNewsWire
- Asia Broadband Sets Registration Deadline to Purchase Gold-Backed Baboons NFT Collection On Inaugural Release by GlobeNewsWire
- Sotera Health Announces Fourth-Quarter and Full-Year 2022 Earnings Release Date by GlobeNewsWire
- Avance Gas: Invitation to Earnings Presentation for the Fourth Quarter of 2022 by GlobeNewsWire
- Diodes Incorporated to Participate at the SIG Susquehanna Technology Conference on March 3 by BusinessWire
- Redfin Reports Investors Are Buying Roughly Half as Many Homes as They Were a Year Ago by BusinessWire
- Wrap Technologies, Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 1, 2023 at 5:00 p.m. ET by GlobeNewsWire
- Blink Charging to Host Fourth Quarter and Year End 2022 Conference Call on Tuesday, February 28, 2023 by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc by EQS Group AG
- Southern Michigan Bancorp, Inc., Announces Fourth Quarter and Full Year 2022 Earnings by GlobeNewsWire
- Alliance Trust PLC - Net Asset Value by GlobeNewsWire
- Adeia and Qorvo Enter into Hybrid Bonding License Agreement by GlobeNewsWire
- FTC Solar to Announce Fourth Quarter and Full Year 2022 Financial Results Tuesday, February 28, 2023 by GlobeNewsWire
- InterDigital Reports Fourth Quarter And Full Year 2022 Financial Results by GlobeNewsWire
- Edible Garden Regains Compliance with Nasdaq Continued Listing Requirements by GlobeNewsWire
- Freight Technologies, Inc. Launches Fr8TMS 3.0, the New Shipper Platform by GlobeNewsWire
- Sugarmade (SGMD) Issues Shareholder Letter and 2023 Corporate Update by GlobeNewsWire
- Alarum: NetNut Enters the End-to-End Retail AI Data Market by GlobeNewsWire
- Compass Diversified Completes Sale of Advanced Circuits by GlobeNewsWire
- The Limestone Boat Company Limited – Corporate Update by GlobeNewsWire
- BBSI Sets Fourth Quarter and Full Year 2022 Conference Call for Wednesday, March 1, 2023, at 5:00 p.m. ET by GlobeNewsWire
- Edge Technologies Named in 2022 Gartner Emerging Tech Impact Radar: 2023 as a Sample Vendor for Digital Twins by GlobeNewsWire
- Portage Biotech to Participate in Citi's 2023 Virtual Oncology Leadership Summit by GlobeNewsWire
- Assembly Biosciences Nominates First Herpesvirus Development Candidate ABI-5366, a Long-Acting HSV-2 Helicase Inhibitor Targeting High-Recurrence Genital Herpes by GlobeNewsWire
- Class 1 Railroad Implements Duos Technologies’ Artificial Intelligence Models in Operations by GlobeNewsWire
- electroCore Completes Sale of New Jersey Tax Benefits by GlobeNewsWire
- Galera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis by GlobeNewsWire
- Euroseas Ltd. Reports Results for the Year and Quarter Ended December 31, 2022 by GlobeNewsWire
- Freeport-McMoRan Receives Copper Mark at PT Freeport Indonesia by BusinessWire
- American Express Opens 14,000 Square Foot Centurion® Lounge in New Location at Seattle-Tacoma International Airport by BusinessWire
- Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc by EQS Group AG
- Xometry to Announce Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023 by GlobeNewsWire
- Progressive Reports January 2023 Results by GlobeNewsWire
- Coherus and Junshi Biosciences Announce Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Clinical Trial Evaluating Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma by GlobeNewsWire
- Hepsiburada’s Initial Assessment of the Recent Earthquake in Türkiye by GlobeNewsWire
- Sienna Announces February Dividend by GlobeNewsWire
- Cellectar Biosciences Hires Dr. Andrei Shustov as New Senior Vice President, Medical by GlobeNewsWire
- Immix Biopharma Subsidiary Nexcella Enters into U.S. GMP Manufacturing Agreement to Expand Ongoing NXC-201 Phase 1b/2 Clinical Trial to the U.S. by GlobeNewsWire
- MarketWise Announces Appointment of Amber Lee Mason Chief Executive Officer and Board Member by GlobeNewsWire
- Datasea Successfully Launches Converged Cloud SaaS Product on China Mobile’s Cloud Open Market and Upgrades AI Chatbot Capabilities by GlobeNewsWire
- Snail, Inc. Announces Ragnarok Expansion Map on ARK: Survival Evolved for Nintendo Switch by GlobeNewsWire
- Study Published in American Journal of Hematology Demonstrates First Reported Evidence of Safe and Successful Boosting of Cytomegalovirus Vaccine-Specific T Cell Immunity in a Stem Cell Transplant Recipient Via Vaccination of a Donor with Triplex by GlobeNewsWire
- SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Three Provisional Patent Applications in the US by GlobeNewsWire